瘤学临床试验的过渡动态:评估临床试验法对合作团体的影响
Kenichi Nakamura1, Koji Takeda2, Akiko M Saito3
1Japan Clinical Oncology Group, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
Japanese journal of clinical oncology
|March 27, 2024
概括
日本的临床试验法增加了运营负担,导致新的和正在进行的瘤临床试验逐渐减少. 需要进行修订以简化流程并支持合作性癌症研究小组.
科学领域:
- 在瘤学瘤学.
- 临床试验 研究 研究 临床试验 临床试验
- 监管科学 监管科学
背景情况:
- 大规模的多中心临床试验对于建立标准癌症治疗至关重要.
- "临床试验法"于2018年4月1日在日本实施,对试验运营产生了重大影响.
- 这一法案对癌症合作社集团的长期影响尚不清楚.
研究的目的:
- 评估"临床试验法"对日本癌症合作组织的影响.
- 分析新开始和正在进行的临床试验的趋势,在该法案执行之前和之后.
主要方法:
- 在九个主要的日本癌症合作组织中进行了一项调查.
- 收集了关于新启动的试验 (FY2017-2022) 和正在进行的试验 (2018-2023) 的数据.
- 通过比较临床试验法案实施前和后的试验数量来评估影响.
主要成果:
- 新启动的试验最初下降,然后升,但最终在2022财年下降.
- 特定的临床试验显示,从2019财年到2022财年持续下降.
- 目前正在进行的试验数量在2020年达到峰值,然后到2023年逐渐减少.
结论:
- "临床试验法"的执行与多中心瘤学临床试验的逐渐减少有关.
- 需要对临床试验法进行全面修订,以简化操作程序.
- 简化该法案对于合作性癌症研究的持续成功至关重要.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.4K
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Drug Administration and Therapy Phases: Overview
457
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
457
